VBI Vaccines Inc/BC Annual Interest Expense in USD from 2015 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: VBI Vaccines Inc/BC quarterly/annual Interest Expense history and growth rate from 2015 to 2023.
VBI Vaccines Inc/BC Interest Expense for the quarter ending March 31, 2024 was $1.82M, a 27.2% increase year-over-year.
VBI Vaccines Inc/BC Interest Expense for the twelve months ending March 31, 2024 was $6.79M, a 51% increase year-over-year.
VBI Vaccines Inc/BC annual Interest Expense for 2023 was $6.4M, a 59.7% increase from 2022.
VBI Vaccines Inc/BC annual Interest Expense for 2022 was $4.01M, a 15.3% decline from 2021.
VBI Vaccines Inc/BC annual Interest Expense for 2021 was $4.73M, a 74.7% increase from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$6.4M	+$2.39M	+59.7%	Jan 1, 2023	Dec 31, 2023	10-K	2024-04-16
2022	$4.01M	-$725K	-15.3%	Jan 1, 2022	Dec 31, 2022	10-K	2024-04-16
2021	$4.73M	+$2.02M	+74.7%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-13
2020	$2.71M	+$512K	+23.3%	Jan 1, 2020	Dec 31, 2020	10-K	2022-03-07
2019	$2.2M	-$436K	-16.6%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-02
2018	$2.63M	-$250K	-8.68%	Jan 1, 2018	Dec 31, 2018	10-K	2020-03-05
2017	$2.88M	+$2.56M	+790%	Jan 1, 2017	Dec 31, 2017	10-K	2019-02-25
2016	$324K	-$781K	-70.7%	Jan 1, 2016	Dec 31, 2016	10-K	2017-03-20
2015	$1.11M			Jan 1, 2015	Dec 31, 2015	10-K	2017-03-20

Showing 1 to 9 of 9 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.